Regulation of the immune system has been shown (1) to result from complex interactions among subsets of lymphocytes and other cells. Some of these interactions are defined as genetically restricted when the effective interaction requires a certain identity among the cells involved. The genetic restrictions reflect the specificity of the T lymphocyte's receptors and are of two types: (a) As originally proposed by Jerne, idiotype specificities determined by Igh-linked genes direct interactions among lymphocyte clones, including T lymphocytes. (b) The other set of restrictions concerns the antigens of the major histocompatibility complex (MHC), 1 H-2 in the mouse. Ly-1 + helper and delayed-type hypersensitivity T cells (DTH) are restricted to react to antigen together with gene products of the I-A or I-A-I-E subregions of the murine H-2 complex, whereas cytolytic T cells are committed to interact with K and D specificities. In this study, we analyzed the genetic restrictions controlling the interactions of suppressor T cell subsets.
(5-7) in suppressor T cell interactions. Although TsF1 and TsF2 are known to express H-2-encoded determinants (4-6), it is not clear whether these structures function as restriction elements. It is also uncertain whether I-J products present on the Tsl or Ts2 cells play any special role in immune regulation.
In this report, we present evidence that (a) the I-J-coded determinants on the immunizing cells restrict the specificity of Ts3 cells induced in the course of immunization with azobenzenearsonate (ABA)-conjugated spleen cells, and (b) there is a requirement for identity between the I-J type of the strains where the Ts2 are generated and the I-J type of cells required for activating the Ts3 cells for suppression to be effective.
The significance of these findings will be discussed in terms of the potential role of the I-J subregion gene product in suppressor cell generation. We suggest that I-J gene products may provide an analogous function to the I-A, I-A-I-E subregion gene product required for antigen presentation in positive immune responses (9) (10) (11) . Antigen Presentation and Immunization. Erythrocyte-free spleen cells were conjugated with ABA by incubating with actiwued ABA diazonium salt solution at a final concentration of 10 raM, as described previously (9) . For immunization, 3 × 107 ABA-coupled spleen cells (ABA-SC) were injected subcutaneously into two separate sites on the dorsal flanks of the mice.
Materials and Methods
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Assay jbr DTH and C)'totoxic T Lympho(ytes (CTL). 5 d after inmmnization, mice were
challenged by injecting 30 ~1 of 10 mM ABA-diazonium salt solution into the left hind footpad. The footpad swelling was measured 24 h later (9) . For CTL assay, spleens were aseptically removed from mice 6-7 d after immunization. Spleen cells were restimulated in vitro for 5 d with irradiated ABA-SC. Culture condition was 7 × 106 responder lymphocytes and 6 X 10 ~ stimulator cells in 1 ml RPMI 1640 plus 5% fetal calf serum (FCS), 5 × 10 s M 2-mercaptoethanol in each well of Costar 24-well tissue culture trays. The cells were kept in a humidified, 5% CO~ atmosphere. Cytolytic activity against ABA-coupled YAC-1 (H-2 a) or EL-4(H-2 b) target cells was measured by 4 h '51Cr release assay (10) .
Suppressor Factors. Either TsFI extracted from spleen cells of A/J mice that had been injected with 5 × 10 7 ABA-SC 7 d earlier (4) or monoclonal suppressor factor produced by Tsl hybridoma of A/J origin, F12 (9) , was used to induce TsF2. A total of 108 cell equivalents of conventional first-order T cell suppressor factor (TsF 0 or 1 ml of F12 culture supernatant was injected intravenously into various strains of mice dailv for 5 d. 2 d after final injection, a spleen cell suspension at 5 x l0 s cells/ml in Hanks' balanced salt solution was prepared and underwent five cycles of freezing and thawing. Supernatant was collected after spinning at 12,000 rpm for 90 rain and stored at -20°C up to 2 too. TsF2, thus prepared, are designated by the strain of mice that were injected with TsF1 of A/J origin and when the Ts2 were generated. For example, TsFz-A.By indicates that the Ts2 cells used to prepare TsF2 were induced in A.By mice. A total of 6 × 107 cell equivalents of TsF~ was injected intravenously on days 4 and 5 after immunization. Because TsF~ requires its administration at the time of immunization to express suppressive activity, this protocol enables us to exclude the carry-over effect of transferred TsFI.
Results
I Region-disparate ABA-coupled Cells Cannot Prime Mice to Be Suppressed by TsFz
We have previously shown that TsF2, obtained from mice given TsF1, mediates suppression by triggering an idiotype-bearing antigen-primed T cell present in the immune population. This cell is the Ts3 cell. To determine whether the activation of Ts3 cells, after immunization with ABA-coupled cells is restricted, B10.A, B10.Br, and B 10.A(4R) cells were coupled with ABA and used to prime A/J mice. Previous studies (9) had indicated the effectiveness of H-2-congenic hapten-coupled cells in ABA priming; in those studies, I-A region identity was found to be necessary for ABAspecific T cell sensitization. As shown in Table I Table II ) were injected on days 4 and 5 at a total dose of 6 × 107 equivalents. § Challenge was performed using 30 #1 of 100 mM ABA on day 5, and 24 h footpad swelling was assessed. mice primed with ABA-coupled A/J cells, and TsF2-B 10.A(3R) suppressed only when F1 mice were immunized with ABA-coupled A.By cells (Table II) . Thus, I-J identity between the TsF2 and the immunizing cells is required for suppression.
The results of the CTL assay (Fig. 2 ) also provide important information with respect to the effect of in vivo antigen priming. The priming with ABA-coupled cells was absolutely specific. For example, spleen cells of (A/J × A.By)F1 mice primed with ABA-coupled A/J cells only killed ABA-coupled YAC-I(H-2 a) target cells but not EL-4(H-2 b) target cells. Furthermore, we also showed that ABA-specific proliferative responses in the F1 hybrid could be selectively activated in a haplotype-specific manner using the same protocol as described here (data not shown). These data strongly suggest that no representation of antigens occurred for activation of either CTL effector cells, T proliferative cells, and Ts3 cells. Collectively, these results indicate that there is a necessity for I-J matching between the TsF2 and the ABAcoupled cells used to induced Ts3 for suppression to occur. cells. This strain combination permits us to evaluate the role of I-J, while it minimizes any significant allogeneic effects and permits the necessary I-A region identity for ABA priming. Groups of these mice received TsF2 induced in either B10.A(3R) or B10.A(5R) mice. The mice were evaluated for ABA-specific responses on day 5. The data shown in Tables III and IV demonstrate the requirement for I-J matching of the hapten-coupled cells used to prime mice for Ts3 and the TsF2 necessary to trigger these cells to manifest suppression.
Mapping of the Inductive and Triggering Signals for Ts3 Functions.
Discussion
The major finding in this report is the genetic restriction of Ts3 activation and function, illustrated by the special relationship between the TsF2 molecule and the ABA-conjugated cells required to activate Ts3. To activate Ts3 cells that, in the ABA system, appear to be the final effector suppressor cells, two events are required. First, the Ts3 must be induced by appropriately presented ligand at the time of priming, and, second, TsFz or a similar signal must trigger the primed cell. The Ts3 cells induced appear to require ligand presented by cells that are I-J identical to the TsF2 subsequently used for complete suppression to occur. Thus, 1-J gene products may be critical for the induction and triggering of Ts3 cells, and this might indicate that I-J gene products play a critical role as a restriction element in the suppressor pathway.
In the ABA system, two clusters of genes are important in the suppression. The Igh-1-1inked set of genes encode idiotype-like structures that govern certain levels of interaction between members of this pathway. Tsl cells induced by ligand in certain strains, e.g., A/J, express idiotype-like structures and elaborate idiotype and I-Jbearing molecules, termed TsF1. This TsF1, in the absence of further antigen, can induce anti-idiotypic Ts2 cells in any recipient strain. Ts2 cells or TsF2 derived from these cells must, however, interact with antigen-primed idiotype-bearing Ts3 cells for suppression to occur. Furthermore, we have also shown that the anti-idiotypic Ts2 and its idiotype target must be H-2 identical. Specifically, this is illustrated by our observation that, when A/J TsF1 is used to induce Ts2 in A.By (H-2 b, Igh-1 e) or C57B1/6 (H-2 b, Igh-lb), the Ts2 can be shown to be active only in A. By (H-2 b, Igh-1 b) and do not function in A/J or C57B1/6. C57B1/6, although H-2 identical to A.By, does not express cross-reactive idiotype. In this study, attention to the rules of matching between the TsF2 and Ts3 cells at the H-2 and Igh-1 region has permitted us to identify the role of I-J-coded determinants in these interactions.
To account for the requirement of I-J identity between the TsF2 and the cells used to induce Ts3, we propose that the Ts3 cells, in addition to ligand, recognize an I-J determinant on certain hapten-coupled cells. This I-J structure is apparently the same that is recognized on the anti-idiotypic I-J-bearing TsFz molecule. Thus, the Ts3 cell behaves as an analogue of the murine Ly-1 + T cell subset described by Schwartz and Paul (11) and others, which recognize I-A, I-A-I-E gene products and antigen on the surface of specialized antigen-presenting cells. If this is the case, I-J gene products are restriction elements for Ts3 activation.
This interpretation is supported by the results from the experiments described herein, in which the (C57B1/6 × A/J)F1 immunized with either B10.A(3R) or B10.A(5R) cells coupled to antigen failed to be suppressed by the TsF2 induced in the I-J-disparate strain. In other words, Ts3 are activated by certain I-J gene products on the immunizing cells in addition to the haptenic determinant. These determinants must be identical with I region gene products of the host in which Ts2 is induced. However, we have not yet obtained structural evidence that the H-2 product on the immunizing cell is the I-J antigen. These experiments are currently in progress using monoclonal anti-I-J antibodies.
Involvement of molecules encoded by the I-J subregion in immunological suppression have been considered for several years. Indeed, I-J restrictions were initially reported in the elegant studies of Tada and colleagues (12) . In addition, most of the Ts and their soluble mediator molecules bear I-J-coded antigens. Certain I-J regionencoded antigens have also been shown to be present on some other nonsuppressor subsets of cells (13) (14) (15) (16) (17) . Functional associations of I-J subregion and suppression were also recently reported for the phenomena in which allogeneic interactions across I-J subregion differences results in the suppression (18) (19) . These studies indicated that anti-I-J-I-J interactions could trigger Ts 1 or Ts2 cells (20) . More recently, I-J-specific (i.e., anti-I-J) allogeneic effect factor has been shown to provide the activation signal for a certain subset of Ts (21). As presented here, the function of TsFz is also restricted to the I-J subregion. In this regard, similar I region restrictions have also been reported for suppression induced by Ts cells in the nitrophenyl system (22) . In other antigen systems, I-C (23) and I-J (24, 25) regions have all been shown to individually determine restrictions.
It is generally considered that antigens must be presented on antigen-presenting (APC) cells to stimulate immune reactivity effectively. APC activity seems to require expression of I region-associated (Ia) antigen and ligand. In some experimental systems, spleen cells chemically coupled with haptenic determinants are also effective as APC. The evidence for the requirement of Ia, or more precisely I-A subregionencoded antigens in the ABA system for effective presentation has been accumulated; ABA-coupled spleen cells that shared I-A subregion with the responding animal were effective in the immunization for ABA-specific DTH (9) , and the immunization was inhibited by the administration of anti-I-A antibodies into the animal (26) . Treatment of APC with monoclonal anti-I-A antibody and complement completely prevents in vitro ABA-specific CTL activity (A. Tominaga and M. I. Greene, manuscript in preparation). Abrogation of immunity by anti-I-A antibodies has also been recently shown in several other antigen systems (28, 29) . Moreover, monoclonal anti-I-A antibodies coupled with ABA induced unresponsiveness rather than inducing DTH (27) . Thus, activational signals associated with I-A molecules are required for the induction of immunity, and the lack of these signals seems to lead to unresponsiveness (27) (28) (29) .
Antigen presentation for activation of Ts, on the other hand, has not been previously considered. It has been simply assumed that the antigens that escaped trapping, processing, and presentation by the reticuloendothelial system (RES) directly bound to and activated Ts. This is based on several observations (30) that the form and route of administration of antigen that led to limited handling by the RES, i.e., such as intravenous administration of cell-bound antigens, etc., were effective inducers of tolerance and suppression. Such Ts were, however, always evaluated in animals or systems that had been primed with antigen. Because the Ts3 activation and subsequent interaction with TsF2 molecules appear to be a major site of I-J restriction, it is not surprising that I-J presentation was not formally identified in these aforementioned studies. Results presented in this report suggest, however, the existence of I-Jrelated antigen presentation for the activation of at least a certain subset of Ts (Ts3). This presentation appears to be an analogous counterpart of I-A-or I-A-I-E-related antigen presentation necessary for helper or DTH immune responses. However, in some unexplained manner, the contribution of I-J-positive APC may also be relevant for certain positive immune responses (16) . Indeed I-J + APC cells may quantitatively and qualitatively govern many aspects of the immune response.
Summary
The genetic restrictions of the activation of third-order suppressor cells (Ts3) were studied in mice, using two different types of anti-azobenzenearsonate (ABA)-immune responses, namely delayed-type hypersensitivity (DTH) and cytotoxic T lymphocyte (CTL) generation. Ts2 cells were induced in several different strains of mice by injecting monoclonal T hybridoma molecules or first-order suppressor factors (TsF1) originating in A/J (H-2 a, Igh-1 ~) mice and then testing the TsF2 molecules derived from these Ts2 in A/J and A.By (H-2 b, Igh-1 e) or (A/J X A.By)F1 (H-2 a/b, Igh-1 e) and (C57B1/6 X A/J)F1 (H-2 b/a, Igh-1 b/e) mice. It was shown that the activity of TsF2 was restricted to the I-J of the strain in which Ts2 was induced. By genetic analysis, restriction was shown to be due to the requirement of H-2 identity between ABAcoupled cells used for Ts3 activation and the strain of the TsFz origin. Moreover, by using H-2-congenic ABA-coupled cells, we were also able to precisely map and demonstrate that ABA-coupled cells I-J identical to TsF2 induced in various strains were necessary for effective suppression to occur. This selective activation of Ts3 suggested the existence of I-J-related antigen presentation for suppression as the counterpart of I-A or I-A-I-E-restricted antigen presentation for positive immune
